Cagrilintide adds a separate fullness signal that tirzepatide does not hit on its own
Note: If it is used in hypovolemic patients, the following may occur: severe peripheral and visceral vasoconstriction, decreased renal perfusion and urine output, poor systemic blood flow despite normal blood pressure, tissue hypoxia, and lactic acidosis
However, a 6-month RCT funded by Kyowa Hakko (n=54) found that taking 250 mg or 1,000 mg of Setria glutathione daily for 6 months significantly increased glutathione levels in blood, buccal cells, and erythrocytes, with the higher dose producing greater increases
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 274,03 per year only 22,84 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF